Drug or treatment
Glumetinib clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Glumetinib that are recruiting, in China. By phase: Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Combining Glumetinib and Fruquintinib for Advanced Colorectal Cancer
This study is testing whether combining two drugs, Glumetinib and Fruquintinib, can help people with advanced colorectal cancer that hasn't responded to previous treatments.
-
Evaluating glumetinib and osimertinib for lung cancer after EGFR-TKI resistance
This study is testing if a new combination of glumetinib and osimertinib can help people with lung cancer who have stopped responding to previous treatments.
Quick answers
How many clinical trials of Glumetinib are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.